v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net earnings $ 3,014 $ 2,660
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 927 978
Stock compensation expense 181 167
Impairment 13 478
Deferred income taxes 14 14
(Gain) loss on divestitures, net (103) (172)
Other adjustments, net (2) 158
Changes in assets and liabilities    
Premium and trade receivables (2,737) (2,329)
Other assets 78 (103)
Medical claims liabilities (5) 401
Unearned revenue (58) 1,878
Accounts payable and accrued expenses (503) 3,127
Other long-term liabilities (84) 583
Other operating activities, net 6 (4)
Net cash provided by operating activities 741 7,836
Cash flows from investing activities:    
Capital expenditures (490) (576)
Purchases of investments (5,770) (4,729)
Sales and maturities of investments 4,147 4,373
Divestiture proceeds, net of divested cash 959 690
Net cash used in investing activities (1,154) (242)
Cash flows from financing activities:    
Proceeds from long-term debt 350 2,170
Payments and repurchases of long-term debt (594) (1,970)
Common stock repurchases (2,181) (1,602)
Proceeds from common stock issuances 37 32
Purchase of noncontrolling interest 0 (87)
Other financing activities, net (5) 0
Net cash used in financing activities (2,393) (1,457)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 7 19
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents (2,799) 6,156
Cash and cash equivalents reclassified (to) from held for sale (3) (36)
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period 17,452 12,330
Cash, cash equivalents and restricted cash and cash equivalents, end of period 14,650 18,450
Supplemental disclosures of cash flow information:    
Interest paid 495 496
Income taxes paid 821 759
The following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:    
Cash and cash equivalents 14,577 18,190
Restricted cash and cash equivalents, included in restricted deposits 73 260
Total cash, cash equivalents and restricted cash and cash equivalents $ 14,650 $ 18,450